newswire

Patient-Led NM Launches Statewide Summits and Video Campaign to Spotlight New Mexicos Healthcare Crisis

Santa Fe, NM, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Patient-Led NM today announced the launch of a series of Healthcare…

2 months ago

Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases

Hinge Bio to receive $10 million upfront and is eligible to receive $95 million for the SLE indication and additional…

2 months ago

POET Technologies and Semtech Launch 1.6T Optical Receivers for AI Networks

POET's Optical Interposer platform integrates Semtech FiberEdge® technology to achieve cutting-edge sensitivity and power efficiency at 200G per lane. September…

2 months ago

DataGrail Summit: California Privacy Protection Agency Head Tom Kemp to Deliver Keynote on Protecting State’s Privacy Enforcement, Legislation & Federal Safeguards

SAN FRANCISCO, Sept. 30, 2025 (GLOBE NEWSWIRE) -- As AI accelerates and regulatory pressure mounts, DataGrail is bringing together industry…

2 months ago

Artelo Biosciences Announces Proposed Underwritten Public Offering

September 29, 2025 19:15 ET  | Source: Artelo Biosciences SOLANA BEACH, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences,…

2 months ago

InboxAlly to Showcase Inbox-First Deliverability at LeadsCon Connect 2025 in Chicago

September 29, 2025 10:00 ET  | Source: InboxAlly New York, NY, Sept. 29, 2025 (GLOBE NEWSWIRE) -- InboxAlly, the award-winning…

2 months ago

TrustStrategy Launches AI-Driven Quant Investment Platform to Advance Global Trading Technologies

Image by TrustStrategy MIAMI, Sept. 29, 2025 (GLOBE NEWSWIRE) -- TrustStrategy, an AI-powered quant investing platform, today announced the launch…

2 months ago

CLINUVEL to advance novel pharmaceutical formulations in preclinical program

Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug delivery platforms for peptides, melanocortinsaim to predict drug…

2 months ago

LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China

September 28, 2025 19:30 ET  | Source: Biogen Inc. TOKYO and CAMBRIDGE, Mass., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Eisai…

2 months ago

Silynxcom Announces First Half of 2025 Financial Results, Expands Client Diversity and Raised $2.9M to Support Growth

September 26, 2025 16:05 ET  | Source: Silynxcom Ltd. Netanya, Israel, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE…

2 months ago